WARMX
LIVE

Serial Number

99087192

Owner

QIAGEN BEVERLY, LLC

Attorney

Randolph E. Digges, III

First Use Date

Jun 12, 2024

Filing Date

Mar 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

WARMX Trademark

Serial Number: 99087192 • Registration: 8020007

WARMX is a trademark filed by QIAGEN BEVERLY, LLC on March 17, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

QIAGEN BEVERLY, LLC (16 trademarks)

SUITE 407J
BEVERLY, MA 01915

Entity Type: 16

Trademark Details

Filing Date

March 17, 2025

Registration Date

November 11, 2025

First Use Anywhere

June 12, 2024

First Use in Commerce

June 12, 2024

Published for Opposition

September 23, 2025

Goods & Services

Chemical, biochemical and biotechnological diagnostic preparations used in science, non-medical reagents, enzymes and chemicals, namely buffer solutions, used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning; chemical test kits for laboratory and research use for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning

Diagnostic preparations for medical and veterinary purposes, namely diagnostics preparations for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 26, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 26, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 26, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 26, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 25, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 25, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2025 NWOS
NEW APPLICATION ENTERED
Mar 17, 2025 NWAP
APPLICATION FILING RECEIPT MAILED
Mar 17, 2025 MAFR